(Q38728340)

PubMed publication ID

5 September 2017

1 reference

title

Vascular Growth Factors and Glomerular Disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

author name string

Christina S Bartlett

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

Susan E Quaggin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

publication date

1 February 2016

1 reference

PubMed publication ID

26863327

Annual Review of Physiology

5 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

page(s)

437-461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

VEGF is required for growth and survival in neonatal mice

13 May 2020

cites work

1 reference

12 December 2020

Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice.

1 reference

12 December 2020

Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation

1 reference

12 December 2020

Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis

1 reference

12 December 2020

VEGF(165) mediates glomerular endothelial repair

1 reference

12 December 2020

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

1 reference

12 December 2020

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

1 reference

12 December 2020

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

1 reference

12 December 2020

Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease

1 reference

12 December 2020

Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway

1 reference

12 December 2020

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

1 reference

12 December 2020

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes

1 reference

12 December 2020

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

1 reference

12 December 2020

Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros

1 reference

12 December 2020

Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression

1 reference

12 December 2020

Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells

1 reference

12 December 2020

Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor

1 reference

12 December 2020

Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis

1 reference

12 December 2020

Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice

1 reference

12 December 2020

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

1 reference

12 December 2020

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo

1 reference

12 December 2020

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

1 reference

12 December 2020

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

1 reference

12 December 2020

Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering

1 reference

12 December 2020

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

12 December 2020

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

12 December 2020

A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains

1 reference

12 December 2020

A molecular and genetic analysis of renalglomerular capillary development.

1 reference

12 December 2020

Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein

1 reference

12 December 2020

The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies

1 reference

12 December 2020

The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis

1 reference

12 December 2020

Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes

1 reference

12 December 2020

Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities

1 reference

12 December 2020

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

1 reference

12 December 2020

Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia

1 reference

12 December 2020

Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system.

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach.

1 reference

12 December 2020

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

1 reference

12 December 2020

The activated mesangial cell: a glomerular "myofibroblast"?

1 reference

12 December 2020

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

1 reference

12 December 2020

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

1 reference

12 December 2020

Pathophysiological consequences of VEGF-induced vascular permeability

1 reference

12 December 2020

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

1 reference

12 December 2020

Integrins and angiogenesis: a sticky business

1 reference

12 December 2020

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

1 reference

12 December 2020

VEGF-C promotes survival in podocytes

1 reference

12 December 2020

Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

1 reference

12 December 2020

Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis

1 reference

12 December 2020

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

12 December 2020

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

1 reference

12 December 2020

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice

1 reference

12 December 2020

Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes

1 reference

12 December 2020

Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis

1 reference

12 December 2020

Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients.

1 reference

12 December 2020

Plasticity of mesangial cells: a basis for understanding pathological alterations

1 reference

12 December 2020

Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome

1 reference

12 December 2020

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

1 reference

12 December 2020

The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice

1 reference

12 December 2020

Angiopoietin-2 impairs revascularization after limb ischemia

1 reference

12 December 2020

Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells

1 reference

12 December 2020

Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia

1 reference

12 December 2020

The glomerular injury of preeclampsia

1 reference

12 December 2020

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

1 reference

12 December 2020

Intracellular mediators of CXCR4-dependent signaling in T cells

1 reference

12 December 2020

Semaphorin3a disrupts podocyte foot processes causing acute proteinuria

1 reference

12 December 2020

Control of chemokine-guided cell migration by ligand sequestration

1 reference

12 December 2020

VEGF inhibition and renal thrombotic microangiopathy

1 reference

12 December 2020

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

1 reference

12 December 2020

Properties of the glomerular barrier and mechanisms of proteinuria

1 reference

12 December 2020

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

1 reference

12 December 2020

Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1

1 reference

12 December 2020

HIV-1 upregulates VEGF in podocytes

1 reference

12 December 2020

Glomerular endothelial cells form diaphragms during development and pathologic conditions

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity

1 reference

12 December 2020

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice

1 reference

12 December 2020

Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium

1 reference

12 December 2020

The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus

1 reference

12 December 2020

The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development

1 reference

12 December 2020

Lymphatic vessels develop during tubulointerstitial fibrosis

1 reference

12 December 2020

PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells

1 reference

12 December 2020

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

1 reference

12 December 2020

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system

1 reference

12 December 2020

The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature

1 reference

12 December 2020

Glomerulogenesis in the developing kidney

1 reference

12 December 2020

The balance of autocrine VEGF-A and VEGF-C determines podocyte survival

1 reference

12 December 2020

Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands

1 reference

12 December 2020

Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.

1 reference

12 December 2020

HIV-associated nephropathy: role of mammalian target of rapamycin pathway.

1 reference

12 December 2020

Targeting the ANGPT-TIE2 pathway in malignancy

1 reference

12 December 2020

Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.

1 reference

12 December 2020

Overexpression of VEGF165b in podocytes reduces glomerular permeability.

1 reference

12 December 2020

Removal of elevated circulating angiopoietin-2 by plasma exchange--a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease

1 reference

12 December 2020

Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

1 reference

12 December 2020

Semaphorins in kidney development and disease: modulators of ureteric bud branching, vascular morphogenesis, and podocyte-endothelial crosstalk

1 reference

12 December 2020

Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy

1 reference

12 December 2020

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

1 reference

12 December 2020

Angiopoietin-1 is essential in mouse vasculature during development and in response to injury

1 reference

12 December 2020

Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes

1 reference

12 December 2020

Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis

1 reference

12 December 2020

Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus

1 reference

12 December 2020

Angiopoietin-2 levels predict mortality in CKD patients

1 reference

12 December 2020

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

1 reference

12 December 2020

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

1 reference

12 December 2020

WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing

1 reference

12 December 2020

Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?

1 reference

12 December 2020

Gene therapy for ischemic heart disease: review of clinical trials

1 reference

12 December 2020

Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury

1 reference

12 December 2020

Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.

1 reference

12 December 2020

VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice

1 reference

12 December 2020

CXC chemokine receptor 7 (CXCR7) regulates CXCR4 protein expression and capillary tuft development in mouse kidney

1 reference

12 December 2020

Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction

1 reference

12 December 2020

The Tie2 receptor antagonist angiopoietin-2 in systemic lupus erythematosus: its correlation with various disease activity parameters.

1 reference

12 December 2020

Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.

1 reference

12 December 2020

Vegfa protects the glomerular microvasculature in diabetes.

1 reference

12 December 2020

Targeted deletion of Vegfa in adult mice induces vision loss

1 reference

12 December 2020

Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis

1 reference

12 December 2020

Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro

1 reference

12 December 2020

Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression

1 reference

12 December 2020

Extracellular matrix phenotype of rat mesangial cells in culture. Biosynthesis of collagen types I, III, IV, and V and a low molecular weight collagenous component and their regulation by dexamethasone.

1 reference

12 December 2020

Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction

1 reference

12 December 2020

Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.

1 reference

12 December 2020

Semaphorin3a signaling, podocyte shape, and glomerular disease

1 reference

12 December 2020

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis

1 reference

12 December 2020

EGF receptor deletion in podocytes attenuates diabetic nephropathy

1 reference

12 December 2020

A lymphatic defect causes ocular hypertension and glaucoma in mice

1 reference

12 December 2020

The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy

1 reference

12 December 2020

Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.

1 reference

12 December 2020

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy

1 reference

12 December 2020

Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population

1 reference

12 December 2020

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

12 December 2020

Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors.

1 reference

12 December 2020

Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats

1 reference

12 December 2020

Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities

1 reference

12 December 2020

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

1 reference

12 December 2020

The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.

1 reference

12 December 2020

Semaphorin III is needed for normal patterning and growth of nerves, bones and heart

1 reference

12 December 2020

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

1 reference

12 December 2020

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis

1 reference

12 December 2020

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 reference

12 December 2020

Increased epidermal growth factor in experimental diabetes related kidney growth in rats

1 reference

12 December 2020

Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells

1 reference

12 December 2020

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

12 December 2020

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

1 reference

12 December 2020

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

12 December 2020

Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli

1 reference

12 December 2020

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

12 December 2020

10.1146/ANNUREV-PHYSIOL-021115-105412

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6450387&resulttype=core&format=json

13 May 2020

PubMed publication ID

26863327

1 reference